medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 3

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (3)

Cutaneous manifestation of disseminated histoplasmosis in a renal transplant patient

Morales LWA, Soria-Segara C, Loayza SE, Tettamanti MD

Language: Spanish
References: 26
Page:
PDF size: 328.17 Kb.


ABSTRACT

Introduction: Histoplasma capsulatum infection frequently occurs in patients with HIV immunosuppression or in transplant recipients receiving immunosuppressive therapy. Primary infection is acquired by inhalation with pulmonary involvement, and may subsequently spread to other organs such as liver, intestines, heart, kidneys, skin or bone tissue. It is very rare in renal transplant patients, although it is common in lung transplantation.
Objective: To present the case of a patient with a history of renal transplantation nine years earlier, who was admitted for presenting skin lesions not typical of histoplasmosis, developing disseminated histoplasmosis two weeks later, without pulmonary involvement.
Clinical Case: Post-renal transplant male patient, aged 65, who developed cutaneous manifestations characterized by erythematous and scaly papules and plaques with crusty and atrophic surfaces, accompanied by persistent fever and lymphadenopathy. There were no pulmonary signs or symptoms of a primary infection. The definitive diagnosis was made by histopathology of skin and cervical nodes, in addition to the growth of H. capsulatum in specific blood cultures for fungi. The patient was treated with liposomal amphotericin B and later with itraconazole on an outpatient basis with favorable evolution.
Conclusion: The case described is important since it does not resemble the typical presentation of this entity, that is, with primary pulmonary and subsequently cutaneous involvement. It is expected to have enriched the knowledge of this disease in transplanted patients.


REFERENCES

  1. Marulanda C, Gartner-López E, Diaz-Gomez C, Aguilar-Molina O. Histoplasmosis diseminada asociada a síndrome de reconstitución inmune en un paciente con virus de la inmunodeficiencia humana. Rev Cubana de Medicina Tropical. 2020 [acceso 16/08/2021];72(3). Disponible en: http://www.revmedtropical.sld.cu/index.php/medtropical/article/view/562/3671.

  2. The neglected histoplasmosis in Latin America Group. Disseminated histoplasmosis in Central and South America, the invisible elephant: the lethal blind spot of international health organizations. AIDS. 2016;30(2):167-70. DOI: https://doi.org/10.1097/QAD.00000000000009612.

  3. Sun NZ, Augustine JJ, Gerstenblith MR. Cutaneous histoplasmosis in renal transplant recipients. Clin Transplant. 2014;28(10):1069-74. DOI: https://doi.org/10.1111/ctr.124093.

  4. Srivastava B, King B, Galan A. An unusual clinical and histologic presentation of disseminated cutaneous histoplasmosis. J Am Acad Dermatol. 2011;65(5):e146-8. DOI: https://doi.org/10.1016/j.jaad.2010.12.0154.

  5. Linder KA, Kauffman CA. Histoplasmosis: Epidemiology, Diagnosis, and Clinical Manifestations. Curr Fungal Infect Rep. 2019;13:120-8. DOI: https://doi.org/10.1007/s12281-019-00341-x5.

  6. Sepúlveda VE, Márquez R, Turissini DA, Goldman WE, Matute DR. Genome Sequences Reveal Cryptic Speciation in the Human Pathogen Histoplasma capsulatum. mBio. 2017;8(6):e01339-17. DOI: https://doi.org/10.1128/mBio.01339-176.

  7. Tobón ÁM. Protocolo de estudio y manejo de histoplasmosis. Infectio. Asociación Colombiana de Infectologia. 2012;16(Supl 3):126-8. DOI: https://doi.org/10.1016/S0123-9392(12)70039-57.

  8. Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49(5):710-6. DOI: https://doi.org/10.1086/6047128.

  9. Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2014;16(2):213-24. DOI: https://doi.org/10.1111/tid.121869.

  10. Ibrahim KY, Carvalho NB, Mimicos EV, Yeh-Li H, Sotto MN, França FO. Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant. Mycopathologia. 2014;178(3-4):273-8. DOI: https://doi.org/10.1007/s11046-014-9793-x10.

  11. Samannodi M, Minshawi F, Hasbun R. Disseminated histoplasmosis in a renal transplantation recipient: Peripheral blood smear was the key. Med Mycol Case Rep. 2021;33(30):1. DOI: https://doi.org/10.1016/j.mmcr.2021.08.00111.

  12. Zanotti P, Chirico C, Gulletta M, Ardighieri L, Casari S, Roldan EQ, et al. Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature. Mediterr J Hematol Infect Dis. 2018;10(1):e2018040. DOI: https://doi.org/10.4084/MJHID.2018.04012.

  13. Grim SA, Proia L, Miller R, Alhyraba M, Costas-Chavarri A, Oberholzer J, et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis. 2012;14(1):17-23. DOI: https://doi.org/10.1111/j.1399-3062.2011.00658.x13.

  14. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis. 2005;7(3-4):109-15. DOI: https://doi.org/10.1111/j.1467-8365.2005.00105.x14.

  15. Zhu C, Wang G, Chen Q, He B, Wang L. Pulmonary histoplasmosis in an immunocompetent patient: A case report and literature review. Exp Ther Med. 2016;12(5):3256-60. DOI: https://doi.org/10.3892/etm.2016.377415.

  16. Batista JM, Martins MAP, Bertollo CM. Primary cutaneous histoplasmosis difficult to treat in immunocompetent patient: case report and literature review. Einstein (Sao Paulo). 2021;19:eRC5488. DOI: https://doi.org/10.31744/einstein_journal/2021RC548816.

  17. Schmiedel Y, Büchi AE, Berezowska S, Pöllinger A, Mühlethaler K, Funke-Chambour M. Autochthonous Case of Pulmonary Histoplasmosis, Switzerland. Emerg Infect Dis. 2021;27(3):966-9. DOI: https://doi.org/10.3201/eid2703.19183117.

  18. Rosado-Odom VM, Daoud J, Johnson R, Allen SD, Lockhart SR, Iqbal N, et al. Cutaneous presentation of progressive disseminated histoplasmosis nine years after renal transplantation. Transpl Infect Dis. 2013;15(2):E64-9. DOI: https://doi.org/10.1111/tid.1205918.

  19. De la Rosa DN, Nakandakari MD, Gutiérrez-Gutiérrez J, Bryson-Malca W. Disseminated pulmonary histoplasmosis with multiple cutaneous lesions: Case report and literature review. Rev Médica Hosp Gen México. 2017;80(3):170-3. DOI: https://doi.org/10.1016/j.hgmx.2016.05.01319.

  20. Paola L, Castillo C, Fernando C, Calcetero G, Uhia CA, Luis Y, et al. Histoplasmosis cutánea primaria. Reporte de caso Primary Cutaneous Histoplasmosis. Case Report. Dermatología Cosmética, Médica y Quirúrgica. 2020 [acceso 16/08/2021];18(4):281-6. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2020/dcm204i.pdf20.

  21. Rog CJ, Rosen DG, Gannon FH. Medical Mycology Case Reports Bilateral adrenal histoplasmosis in an immunocompetent man from Texas. Med Mycol Case Rep. 2016;14:4-7. DOI: http://dx.doi.org/10.1016/j.mmcr.2016.11.00621.

  22. Kumar N, Singh S, Govil S. Adrenal histoplasmosis: clinical presentation and imaging features in nine cases. Abdom Imaging. 2003;28(5):703-8. DOI: https://doi.org/10.1007/s00261-003-0010-522.

  23. Freifeld AG, Wheat LJ, Kaul DR. Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14(6):601-5. DOI: https://doi.org/10.1097/MOT.0b013e3283329c9a23.

  24. Freifeld AG, Wheat LJ, Kaul DR. Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14(6):601-5. DOI: https://doi.org/10.1097/MOT.0b013e3283329c9a24.

  25. Fernandes AR, Viana LA, Mansur JB, Françoso MM, Santos DWCL, Silva HT, et al. Sepsis-like histoplasmosis in a kidney transplant patient. J Bras Nefrol. 2018;40(1):95-7. DOI: https://doi.org/10.1590/1678-4685-JBN-376725.

  26. Trinh SA, Echenique IA, Penugonda S, Angarone MP. Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2018;20(5):e12963. DOI: https://doi.org/10.1111/tid.1296326.




2020     |     www.medigraphic.com